Intratumoral Gene Mediated Cytotoxic Immunotherapy in Patients With Resectable Non-Small Cell Lung Cancer

Condition:   Lung Cancer Intervention:   Biological: AdV-tk (aglatimagene besadenovec) + valacyclovir Sponsors:   Advantagene, Inc.;   University of Pennsylvania Recruiting - verified April 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials